MSCV-Neo-GFP/empty Citations (2)
Originally described in: Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, Grem JL, Lazenby AJ, Grunkemeyer JA, Hollingsworth MA, Grandgenett PM, Egeblad M, Park Y, Tuveson DA, Vakoc CR Cell. 2017 Aug 24;170(5):875-888.e20. doi: 10.1016/j.cell.2017.07.007. Epub 2017 Jul 27. PubMed Journal
Articles Citing MSCV-Neo-GFP/empty
| Articles |
|---|
| EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Kim HR, Yim J, Yoo HB, Lee SE, Oh S, Jung S, Hwang CI, Shin DM, Kim T, Yoo KH, Kim YS, Lee HW, Roe JS. NAR Cancer. 2021 Jun 17;3(2):zcab023. doi: 10.1093/narcan/zcab023. eCollection 2021 Jun. PubMed |
| RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Hunt BG, Davis JC, Fox LH, Vicente-Munoz S, Lester C, Wells SI, Waltz SE. Oncogene. 2023 May;42(21):1716-1727. doi: 10.1038/s41388-023-02688-5. Epub 2023 Apr 7. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.